KR20120121677A - Novel diamine compound containing terpyridine or phenanthroline and method use the same - Google Patents

Novel diamine compound containing terpyridine or phenanthroline and method use the same Download PDF

Info

Publication number
KR20120121677A
KR20120121677A KR1020110039621A KR20110039621A KR20120121677A KR 20120121677 A KR20120121677 A KR 20120121677A KR 1020110039621 A KR1020110039621 A KR 1020110039621A KR 20110039621 A KR20110039621 A KR 20110039621A KR 20120121677 A KR20120121677 A KR 20120121677A
Authority
KR
South Korea
Prior art keywords
compound
formula
terpyridine
chemical formula
phenanthrosine
Prior art date
Application number
KR1020110039621A
Other languages
Korean (ko)
Other versions
KR101311767B1 (en
Inventor
원종찬
오재범
박노균
정현민
김용석
정택모
김병각
Original Assignee
한국화학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국화학연구원 filed Critical 한국화학연구원
Priority to KR1020110039621A priority Critical patent/KR101311767B1/en
Priority to PCT/KR2012/002367 priority patent/WO2012148090A2/en
Publication of KR20120121677A publication Critical patent/KR20120121677A/en
Application granted granted Critical
Publication of KR101311767B1 publication Critical patent/KR101311767B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/22Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)

Abstract

PURPOSE: A diamine compound containing terpyridine or phenanthroline functional groups is provided to be used as a catalytic and dielectric material. CONSTITUTION: A diamine compound containing terpyridine or phenanthroline groups is denoted by chemical formula 1. A method for preparing the diamine compounds comprises: a step of reacting a compound of chemical formula 2 with a compound of chemical formula 3 to prepare a compound of chemical formula 4; a step of reducing the compound of chemical formula 4 to prepare a compound of chemical formula 1a.

Description

터피리딘 또는 페난쓰롤린 기능기를 함유하는 새로운 구조의 디아민의 제조와 이의 응용{Novel diamine compound containing terpyridine or phenanthroline and method use the same}Preparation and Application of Novel Diamine Compound Containing Terpyridine or phenanthroline and Method Use the Same

본 발명은 터피리딘과 페난쓰롤린 관능기를 포함하는 디아민 및 그 제조방법에 관한 것이다. The present invention relates to a diamine comprising a terpyridine and a phenanthrosine functional group and a preparation method thereof.

거대분자 화학분야에서 이용되고, 가장 중요시 여겨지는 분자간 상호작용은 금속과 유기 리간드의 배위결합이다. 이러한 금속과 유기 리간드의 배위 결합은 금속과 유기 리간드의 상호작용을 이용하여 유기분자의 고유한 특성에 금속의 다양한 성질과 특성을 도입할 수 있어 여러 분야에 응용이 가능하다.  The most important intermolecular interaction, used in macromolecular chemistry, is the coordination of metals and organic ligands. The coordination bond between the metal and the organic ligand can be applied to various fields by introducing various properties and properties of the metal into the unique properties of the organic molecules by using the interaction of the metal and the organic ligand.

또한 이 상호작용을 이용하기 위하여, 유기 리간드의 기능기로써, 터피리딘과 페난쓰롤린과 같은 리간드들이 많이 상용되어지고 있다. 터피리딘이나 페난쓰롤린과 같은 기능기가 도입된 리간드를 이용하여, 여러 가지 금속과 금속 착화합물을 제조하여, 다양한 분야에 도입되어 지고 있다. 예로써, 류테늄 금속 착화합물로 이루어진 염료를 나노디바이스에 적용하여 분자 스위치로써 응용되고 있으며, 터피리딘 금속 착화합물을 구형이나 고리형으로 제조하여 최근 태양전지용 재료로 관심을 받고 있는 플러렌에 터피리딘 금속 착화합물을 도입하는 연구도 많이 보고되어지고 있다. In order to take advantage of this interaction, ligands such as terpyridine and phenanthrosine are commonly used as functional groups of organic ligands. Various ligands have been introduced into various fields by preparing various metals and metal complex compounds using ligands having functional groups such as terpyridine and phenanthrosine. For example, a dye consisting of a ruthenium metal complex is applied to a nanodevice and applied as a molecular switch, and a terpyridine metal complex is made of spherical or cyclic to form a terpyridine metal complex of a fullerene, which has recently been attracting attention as a material for solar cells. A lot of researches have been reported.

터피리딘을 고분자 측쇄에 도입함으로써, 금속 착물을 도입할 수 있는 고분자 설계와 제조도 보고되고 있다. By introducing terpyridine into the polymer side chain, a polymer design and manufacture capable of introducing a metal complex have also been reported.

또한 터피리딘을 이용한 금속 착화합물은 분자설계에 있어서, 거대분자 구조 설계가 가능하다. 즉, 이러한 구조설계를 이용하여, 덴드리머, 마이셀, 레진등을 나노 반응기로 제조하고, 이를 새로운 촉매로 이용하는 문헌도 보고되고 있다. In addition, the metal complex using terpyridine can design macromolecular structure in molecular design. In other words, using such a structural design, a document has been reported to produce dendrimers, micelles, resins, etc. in a nano reactor, using them as a new catalyst.

이와 같이 금속과 배위결합을 할 수 있는 유기 리간드로 사용될 수 있고 고분자 합성에 기능기인 터피리딘과 페난쓰롤린을 가지는 단량체로도 사용가능한 새로운 디아민 화합물의 합성이 요구되어 진다.As such, there is a need for the synthesis of new diamine compounds that can be used as organic ligands capable of coordinating metals and can also be used as monomers having terpyridine and phenanthrosine as functional groups in polymer synthesis.

본 발명은 터피리딘과 페난쓰롤린 기능기를 포함하는 새로운 디아민 화합물과 그 제조방법을 제공한다.The present invention provides a novel diamine compound comprising a terpyridine and a phenanthrosine functional group and a method for preparing the same.

또한 본 발명은 터피리딘과 페난쓰롤린 기능기를 포함하는 새로운 디아민 화합물을 단량체로 사용하여 제조된 공중합체를 제공한다.The present invention also provides a copolymer prepared by using a new diamine compound containing a terpyridine and a phenanthrosine functional group as a monomer.

본 발명은 디안하이드라이드, 디카복실산, 디에스터 등의 단량체와 반응하여 고분자를 형성할 수 있으며 금속이나 금속 산화물과 효과적으로 배위결합을 할 수 있는 터피리딘 또는 페난쓰롤린 기능기를 포함하는 디아민 화합물을 제공한다. 이러한 본 발명의 터피리딘 또는 페난쓰롤린 기능기를 포함하는 디아민 화합물은 하기 화학식 1로 표시된다.The present invention provides a diamine compound comprising a terpyridine or phenanthrosine functional group capable of reacting with monomers such as dianhydride, dicarboxylic acid, diester, and the like to form a polymer and effectively coordinating with metals or metal oxides. do. The diamine compound including the terpyridine or phenanthrosine functional group of the present invention is represented by the following formula (1).

[화학식 1][Formula 1]

Figure pat00001
Figure pat00001

[상기 화학식 1에서,[In Formula 1,

R은 아민기 또는 -O-Ar-NH2이며, Ar은 C6~C12아릴이며;R is an amine group or -O-Ar-NH 2 , and Ar is C 6 -C 12 aryl;

n은 0 내지 2의 상수이며;n is a constant from 0 to 2;

A는 하기 구조식에서 선택되는 어느 하나이다.]A is any one selected from the following structural formulas.]

Figure pat00002
Figure pat00002

상기 화학식 1에서 C6~C12아릴의 아릴은 특별히 한정이 있는 것은 아니나 페닐, 나프틸, 바이페닐, 안트라세닐 및 플루오레닐중 선택되는 하나일 수 있으며 페닐이 바람직하다.In Formula 1, aryl of C 6 to C 12 aryl is not particularly limited, but may be one selected from phenyl, naphthyl, biphenyl, anthracenyl, and fluorenyl, and phenyl is preferable.

또한 본 발명의 터피리딘 또는 페난쓰롤린 기능기를 포함하는 디아민 화합물의 합성의 일면은 다음과 같다.In addition, one aspect of the synthesis of the diamine compound containing a terpyridine or phenanthrosine functional group of the present invention is as follows.

하기 화학식 1a로 표시 되는 터피리딘 또는 페난쓰롤린 기능기를 포함하는 디아민 화합물은,The diamine compound containing a terpyridine or phenanthrosine functional group represented by the formula (1a),

하기 화학식 2의 화합물과 하기 화학식 3의 화합물을 반응시켜 하기 화학식 4의 화합물을 제조하는 단계;Preparing a compound of Chemical Formula 4 by reacting a compound of Chemical Formula 2 with a compound of Chemical Formula 3;

하기 화학식 4의 화합물을 환원하여 하기 화학식 1a의 화합물을 제조하는 단계;를 포함하여 제조한다.To prepare a compound of formula 1a by reducing the compound of formula (4).

[화학식 1a][Formula 1a]

Figure pat00003
Figure pat00003

[화학식 2][Formula 2]

Figure pat00004
Figure pat00004

[화학식 3](3)

A-X    A-X

[화학식 4][Formula 4]

Figure pat00005
Figure pat00005

[화학식 1a, 화학식 2 내지 화학식 4에서,[Formula 1a, Formula 2 to Formula 4,

n은 0 내지 2의 상수이며; n is a constant from 0 to 2;

X는 할로겐이며;X is halogen;

A는 하기 구조식에서 선택되는 어느 하나이다.]A is any one selected from the following structural formulas.]

Figure pat00006
Figure pat00006

상기 화학식 2의 화합물은, 하기 화학식 6의 화합물로 하기 화학식 7을 제조하는 단계;The compound of Formula 2 is prepared by the following formula (7) to the compound of formula (6);

하기 화학식 7을 하기 화학식 2로 제조하는 단계;를 포함하여 제조되는 터피리딘기 또는 페난쓰롤린기를 포함하여 제조 될 수 있다.It may be prepared to include a terpyridine group or a phenanthrosine group prepared by the following;

[화학식 6][Formula 6]

Figure pat00007
Figure pat00007

[화학식 7][Formula 7]

Figure pat00008
Figure pat00008

[상기 화학식 6 또는 7에서, X는 할로겐이다.][In Formula 6 or 7, X is a halogen.]

본 발명의 터피리딘 또는 페난쓰롤린 기능기를 포함하는 디아민 화합물의 합성의 또 다른 일면은 다음과 같다.Another aspect of the synthesis of the diamine compound containing a terpyridine or phenanthrosine functional group of the present invention is as follows.

즉, 하기 화학식 1b로 표시 되는 터피리딘 또는 페난쓰롤린 기능기를 포함하는 디아민 화합물은, That is, the diamine compound containing a terpyridine or phenanthrosine functional group represented by the general formula (1b),

하기 화학식 3의 화합물과 하기 화학식의 8화합물을 반응시켜 하기 화학식 9의 화합물을 제조하는 단계;Preparing a compound of Chemical Formula 9 by reacting the compound of Chemical Formula 3 with the compound of Chemical Formula 8;

하기 화학식 9을 산화하여 하기 화학식 10의 화합물을 제조하는 단계;Preparing a compound of Chemical Formula 10 by oxidizing Chemical Formula 9;

하기 화학식 10의 화합물과 하기 화학식 11의 화합물을 반응하여 하기 화학식 12의 화합물을 제조하는 단계;Preparing a compound of Chemical Formula 12 by reacting a compound of Chemical Formula 10 with a compound of Chemical Formula 11;

하기 화학식 12의 화합물을 환원하여 하기 화학식 1b의 화합물을 제조하는 단계;를 포함한다.It comprises; reducing the compound of Formula 12 to produce a compound of Formula 1b.

[화학식 1b][Chemical Formula 1b]

Figure pat00009
Figure pat00009

[화학식 3](3)

A-X   A-X

[화학식 8][Formula 8]

Figure pat00010
Figure pat00010

[화학식 9][Chemical Formula 9]

Figure pat00011
Figure pat00011

[화학식 10][Formula 10]

Figure pat00012
Figure pat00012

[화학식 11][Formula 11]

Figure pat00013
Figure pat00013

[화학식 12][Chemical Formula 12]

Figure pat00014
Figure pat00014

[화학식 1b, 화학식 3 및 화학식 8 내지 화학식 12에서,In Chemical Formula 1b, Chemical Formula 3, and Chemical Formulas 8 to 12,

X는 할로겐이며; A 또는 Ar은 제 1항의 화학식 1에서의 정의와 동일하다.]X is halogen; A or Ar is the same as defined in formula 1 of claim 1.]

또한 본 발명은 상기 화학식 1로 표시되는 터피리딘기 또는 페난쓰롤린기를 포함하는 디아민 화합물과 디안하이드라이드, 디카복실산 및 디에스터에서 선택되는 하나 또는 둘이상의 혼합물을 반응하여 제조된 중합체를 제공한다.In another aspect, the present invention provides a polymer prepared by reacting a diamine compound comprising a terpyridine group or a phenanthrosine group represented by Formula 1 with a mixture of one or two or more selected from dianhydrides, dicarboxylic acids and diesters.

본 발명은 터피리딘과 페난쓰롤린 기능기를 포함하는 신규 디아민 화합물을 제공한다.The present invention provides novel diamine compounds comprising terpyridine and phenanthrosine functional groups.

또한 본 발명에 따른 터피리딘과 페난쓰롤린 기능기를 포함하는 신규 디아민 화합물은 디안하이드라이드, 디카복실산, 디에스터 등의 단량체와 반응하여 고분자를 형성할 수 있다.In addition, the novel diamine compound including the terpyridine and phenanthrosine functional groups according to the present invention can react with monomers such as dianhydride, dicarboxylic acid, diester, and the like to form a polymer.

또한 본 발명에 따른 터피리딘 또는 페난쓰롤린 기능기를 포함하는 디아민 화합물은 디안하이드라이드와 반응하여 폴리이미드를 제조하는 경우 열적 성질과 전기적 특성이 우수한 폴리이미드에 터피리딘과 페난쓰롤린 기능기를 이미드 측쇄에 도입하므로써 금속이나 금속 산화물과의 배위 결합을 효과적으로 도입시킬 수 있는 장점이 있다.In addition, the diamine compound containing a terpyridine or phenanthrosine functional group according to the present invention imides a terpyridine and phenanthrosine functional group to a polyimide excellent in thermal and electrical properties when the polyimide is prepared by reaction with dianhydride By introducing into the side chain there is an advantage that can effectively introduce the coordination bond with the metal or metal oxide.

도 1은 실시예 1 화합물의 1H NMR 을 나타낸 것이다.
도 2은 실시예 4의 4-1 화합물의 1H NMR 을 나타낸 것이다.
도 3는 실시예 4의 4-1 화합물의 Mass 스펙트럼을 나타낸 것이다.
도 4는 본 발명의 실시예 1을 PMDA와 중합하여 얻은 PAA와 PI의 FT-IR 을 나타낸 것이다.
1 shows the 1 H NMR of the compound of Example 1.
2 shows 1 H NMR of the compound 4-1 of Example 4. FIG.
Figure 3 shows the mass spectrum of the 4-1 compound of Example 4.
Figure 4 shows the FT-IR of PAA and PI obtained by polymerizing Example 1 of the present invention with PMDA.

이하 본 발명을 실시예를 통하여 상세히 설명하나, 본 발명은 당업자에게 그 실시예의 범위에 국한되는 것이 아니다.  Hereinafter, the present invention will be described in detail with reference to examples, but the present invention is not limited to those skilled in the art.

[실시예1] 화합물 1(4′-(3,5-디아미노페닐)-2,2′ : 6′,2′′-터피리딘 (4′-(3,5-Diaminophenyl)-2,2′:6′,2′′-terpyridine)의 제조Example 1 Compound 1 (4 ′-(3,5-Diaminophenyl) -2,2 ′: 6 ′, 2 ′ ′-terpyridine (4 ′-(3,5-Diaminophenyl) -2,2 ′: 6 ′, 2 ′ ′-terpyridine)

화합물 1-1Compound 1-1 (2,6-Dibromo-4-nitropyridine)의 제조 Preparation of (2,6-Dibromo-4-nitropyridine)

Figure pat00015
Figure pat00015

2,6-디브로모-4-니트로피리딘은 2,6-디브로모피리딘을 출발물질로 하여 다음의 특허에 제시된 방법과 동일한 방법을 이용하여 제조하였다(WO 2005/026164, PTC/EP 2004/052229). 2,6-Dibromo-4-nitropyridine was prepared using 2,6-dibromopyridine as a starting material using the same method as described in the following patent (WO 2005/026164, PTC / EP 2004). / 052229).

1H NMR (CDCl3): 8.19 (s, 2H)
1 H NMR (CDCl 3 ): 8.19 (s, 2H)

화합물 1-2Compound 1-2 (2-(Tributylstannyl)pyridine)의 제조Preparation of (2- (Tributylstannyl) pyridine)

Figure pat00016
Figure pat00016

2-브로모피리딘을 출발 물질로 사용하여 다음의 문헌에 제시된 동일한 방법을 이용하여 제조하였다(R. Shetty et. al., Tetrahedron Lett., 2007, 48, 113-117). 2-Bromopyridine was used as starting material and prepared using the same method set forth in the following literature (R. Shetty et. Al., Tetrahedron Lett. , 2007 , 48 , 113-117).

1H NMR (CDCl3): 8.75-8.72 (m, 1H), 7.51-7.38 (m, 2H), 7.13-7.08 (m, 1H), 1.88 (t, 6H), 1.67-1.45 (m, 6H), 1.25-1.08 (m, 6H), 0.94 (t, 9H)
1 H NMR (CDCl 3 ): 8.75-8.72 (m, 1H), 7.51-7.38 (m, 2H), 7.13-7.08 (m, 1H), 1.88 (t, 6H), 1.67-1.45 (m, 6H) , 1.25-1.08 (m, 6H), 0.94 (t, 9H)

화합물 1-3Compound 1-3 (4'-Nitro-2,2':6',2''-terpyridine) 의 제조 Preparation of (4'-Nitro-2,2 ': 6', 2 ''-terpyridine)

Figure pat00017
Figure pat00017

질소 분위기하인 플라스크에 2,6-디브로모-4-니트로피리딘(5.64 g, 0.02 mol)과 2-(트리부틸스테닐)피리딘(14.7 g, 0.04 mol)을 넣고 무수 톨루엔을 이용하여 상온에서 교반하면서 녹인다. 테트라키스(트리페닐포스핀)팔라듐(0) (Tetrakis(triphenylphosphine)palladium(0) (0.23 g, 0.2 mol)을 첨가한 후, 질소를 분위기를 유지시켜주면서, 24 시간 동안 120oC를 유지시키면서 환류 하였다. 반응 종결 후, 실온으로 냉각하고, 암모늄 클로라이드(Ammonium chloride) 용액 20ml를 첨가 한 후, 톨루엔을 이용하여 3회 추출하고, 추출된 유기 용매를 MgSO4를 이용하여 건조하였다. 유기용매를 감압 하에서 제거한 후, 다시 물을 첨가하고, 염산을 이용하여 산 처리 후, 30분간 교반해 준다. 디클로로메탄을 이용하여 추출해 주고 2N-NaOH 수용액을 이용하여 중성화 시켜준다. 중성화된 유기 용매를 MgSO4를 이용하여 건조한 후, 감압 하에서 용매를 제거 하고, 여기에 헥산을 첨가하여 흰색 고체 결정을 얻어 제조하였다.2,6-dibromo-4-nitropyridine (5.64 g, 0.02 mol) and 2- (tributylstenyl) pyridine (14.7 g, 0.04 mol) were added to the flask under nitrogen atmosphere at room temperature using anhydrous toluene. Melt while stirring. After addition of tetrakis (triphenylphosphine) palladium (0) (0.23 g, 0.2 mol), nitrogen was maintained at 120 ° C. for 24 hours while maintaining the atmosphere. After completion of the reaction, the reaction mixture was cooled to room temperature, 20 ml of ammonium chloride solution was added, followed by extraction three times using toluene, and the extracted organic solvent was dried using MgSO 4 . after removal under reduced pressure, and after the acid treatment using an addition of water, and hydrochloric acid, again, makes it stirred for 30 min. to give extracted with dichloromethane gives was neutralized using a 2N-NaOH aqueous solution. the neutralized organic solvent MgSO 4 After drying using, the solvent was removed under reduced pressure, and hexane was added thereto to obtain white solid crystals.

1H NMR (CDCl3): δ 9.16 (s, 2H), 8.77-8.75 (m, 2H), 8.64-8.60 (m, 2H), 7.94-7.88 (m, 2H), 7.44-7.39 (m, 2H)
1 H NMR (CDCl 3 ): δ 9.16 (s, 2H), 8.77-8.75 (m, 2H), 8.64-8.60 (m, 2H), 7.94-7.88 (m, 2H), 7.44-7.39 (m, 2H )

화합물 1-4Compound 1-4 (4'-Amino-2,2':6',2''-terpyridine)의 제조Preparation of (4'-Amino-2,2 ': 6', 2 ''-terpyridine)

Figure pat00018
Figure pat00018

질소 기류상태인 플라스크에 4'-니트로-2,2',6',2''-터피리딘 (2.7 g, 0.01 mol)과 에탄올 40ml를 넣고 약 10분간 교반한 후, 5% Pd/C (0.5 g)을 넣어 준다. 그 후, 하이드라진 하이드레이트 10ml를 30분 동안 서서히 적가한 후, 수소 기체의 발생 여부를 확인한다. 온도를 80oC로 승온하고 24시간 동안 교반 환류시킨다. 반응이 종결된 후, 여과하여 촉매를 제거한다. 용매를 가압 하에서 농축시키고, 에틸아세테이트로 추출한다. 추출된 용액을 소금물로 세척하고, MgSO4를 이용하여 건조한 후, 여과하고, 다시 용매를 감압 하에 용매를 제거하고, 건조하여 제조하였다. 4'-nitro-2,2 ', 6', 2 ''-terpyridine (2.7 g, 0.01 mol) and 40 ml of ethanol were added to the flask under nitrogen flow and stirred for about 10 minutes, followed by 5% Pd / C ( Add 0.5 g). Thereafter, 10 ml of hydrazine hydrate is slowly added dropwise for 30 minutes, and then it is checked whether hydrogen gas is generated. The temperature is raised to 80 ° C. and stirred at reflux for 24 hours. After the reaction is complete, the catalyst is removed by filtration. The solvent is concentrated under pressure and extracted with ethyl acetate. The extracted solution was washed with brine, dried using MgSO 4 , filtered, and the solvent was removed by further removing the solvent under reduced pressure and drying.

1H NMR (CDCl3): δ 8.68-8.59 (m, 4H), 7.86-7.80 (m, 2H), 7.74 (s, 2H), 7.32-7.28 (m, 2H), 4.35 (b s, 2H)
1 H NMR (CDCl 3 ): δ 8.68-8.59 (m, 4H), 7.86-7.80 (m, 2H), 7.74 (s, 2H), 7.32-7.28 (m, 2H), 4.35 (bs, 2H)

화합물 1-5Compound 1-5 (4'-Bromo-2,2':6',2''-terpyridine)의 제조Preparation of (4'-Bromo-2,2 ': 6', 2 ''-terpyridine)

Figure pat00019
Figure pat00019

4'-아미노-2,2':6',2''-터피리딘(2.36 g, 0.01 mol), 48% HBr(20 ml)를 넣고 얼음물로 내부 온도를 5oC로 냉각 하고, Br2 3ml(0.05 mol)을 천천히 적가 한다. NaNO2를 증류수 10ml에 녹여 첨가하고 24h 동안 교반한다. 반응이 종결되면 증류수 200ml에 이 혼합물을 붓고, 10% NaOH 용액을 이용하여 중화 시킨다. 에틸 아세테이트를 이용하여 추출하고, 소금물로 여러번 씻어 준다. 유기층을 MgSO4로 건조하고, 감압 증류하여 용매를 제거하여 제조하였다. Add 4'-amino-2,2 ': 6', 2 ''-terpyridine (2.36 g, 0.01 mol), 48% HBr (20 ml), cool the internal temperature to 5 o C with ice water, Br 2 Slowly add 3 ml (0.05 mol) dropwise. NaNO 2 is dissolved in 10 ml of distilled water and added and stirred for 24 h. At the end of the reaction, the mixture is poured into 200 ml of distilled water and neutralized with 10% NaOH solution. Extract with ethyl acetate and wash several times with brine. The organic layer was dried over MgSO 4 and distilled under reduced pressure to prepare a solvent.

1H NMR (CDCl3): δ 8.75-8.69 (m, 2H), 8.65 (s, 2H), 8.60-8.57 (m, 2H), 7.89-7.83 (m, 2H), 7.38-7.33 (m, 2H)
1 H NMR (CDCl 3 ): δ 8.75-8.69 (m, 2H), 8.65 (s, 2H), 8.60-8.57 (m, 2H), 7.89-7.83 (m, 2H), 7.38-7.33 (m, 2H )

화합물 1-6Compound 1-6 (1-Bromo-3,5-dinitrobenzene)의 제조Preparation of (1-Bromo-3,5-dinitrobenzene)

Figure pat00020
Figure pat00020

1,3-디니트로벤젠(1,3-Dinitrobenzene)(10 g, 0.06 mol)를 진한 황산 60 mL로 녹인 다음 80oC를 유지하면서 N-브로모숙신이미드(N-Bromosuccinimide)(15 g, 0.083 mol)를 10분씩 9회에 걸쳐 적가하고 95oC로 승온하여 24시간 동안 반응시켰다. 반응 종결 후, 얼음물에 붓고 생성된 침전물을 여과한 후, 증류수로 수 회 세척하고 메탄올(Methanol)로 재결정하여 제조하였다.1,3-dinitrobenzene (1,3-Dinitrobenzene) (10 g , 0.06 mol) while maintaining the dissolved in 60 mL concentrated sulfuric acid and then 80 C o N - bromosuccinimide (N -Bromosuccinimide) (15 g , 0.083 mol) was added dropwise nine times for 10 minutes, and the reaction mixture was heated to 95 ° C. for 24 hours. After completion of the reaction, the resultant was poured into iced water and the resulting precipitate was filtered, washed several times with distilled water and prepared by recrystallization with methanol (Methanol).

1H NMR (CDCl3): δ 9.00 (s, 1H), 8.71 (s, 2H)
1 H NMR (CDCl 3 ): δ 9.00 (s, 1H), 8.71 (s, 2H)

화합물 1-7Compound 1-7 (3,5-dinitrophenylboronic acid, pinacol ester)의 제조Preparation of (3,5-dinitrophenylboronic acid, pinacol ester)

Figure pat00021
Figure pat00021

1-브로모-3,5-디니트로벤젠(1 g, 4 mmol), 비스(피나콜라토)디보란(Bis(pinacolato)diboran(1.23 g, 4.9 mmol), 디클로로[1,1'-비스(디페닐포스피노)페로센]팔라듐(II) 디클로로메탄)(Dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane)(0.17 g, 0.2 mmol)과 포타슘 아세테이트(photassium acetate)(1.2 g, 12 mmol)을 글로브 박스에서 플라스크에 넣는다. 질소 하에서 무수 DMF(50ml)를 첨가하고, 80oC에서 24시간 동안 반응 시킨다. 반응 종료 후, 여과하여 촉매부분을 제거 하고, 감압 하에서 용매를 제거한다. 아세토니트릴(Acetonitrile)을 사용하여 재결정하여 제조하였다. 1-bromo-3,5-dinitrobenzene (1 g, 4 mmol), bis (pinacolato) diborane (Bis (pinacolato) diboran (1.23 g, 4.9 mmol), dichloro [1,1'-bis Dichloro [1,1'-bis (diphenylphosphino) ferrocene] palladium (II) dichloromethane) (0.17 g, 0.2 mmol) and potassium acetate (photassium acetate) (dichlorophosphino) ferrocene] palladium (II) dichloromethane) 1.2 g, 12 mmol) is added to the flask in a glove box. Anhydrous DMF (50 ml) is added under nitrogen and reacted at 80 ° C. for 24 hours. After completion of the reaction, the catalyst portion was removed by filtration and the solvent was removed under reduced pressure. Prepared by recrystallization using acetonitrile.

1H NMR (CDCl3): δ 9.06 (t, 1H), 8.88 (d, 2H), 1.35 (s, 12H)
1 H NMR (CDCl 3 ): δ 9.06 (t, 1H), 8.88 (d, 2H), 1.35 (s, 12H)

화합물 1-8Compound 1-8 (4′-(3,5-Dinitrophenyl)-2,2′:6′,2′′-terpyridine)의 제조 Preparation of (4 ′-(3,5-Dinitrophenyl) -2,2 ′: 6 ′, 2 ′ ′-terpyridine)

Figure pat00022
Figure pat00022

4'-브로모-2,2':6',2''-터피리딘(624 mg, 2 mmol)을 1,2-디메톡시에탄(1,2-Dimethoxyethane) 15ml로 녹인다. 실온에서 30분간 교반하여 반응기 내부를 질소 분위기로 만들고 3,5-디니트로페닐보로닉 에시드, 피나콜 에스터(617 mg, 2.1 mmol)과 테트라키스(트리페닐포스핀)팔라듐(0)(Tetrakis(triphenylphosphine)palladium(0))(60 mg, 5 mmol%) 그리고 2M-Na2CO3 용액을 2 ml를 첨가하고 85 oC로 유지하면서 24시간 반응시켰다. 반응 종결 후, 실온으로 냉각하여 증류수 50 mL을 반응 물질에 첨가하여 반응을 종결시키고, 2N-HCl로 약산성화(PH = 5) 시켰다. 감압 여과하고 증류수로 수회 세척하고, 메탄올을 이용하여 재결정하여 제조하였다.Dissolve 4'-bromo-2,2 ': 6', 2 ''-terpyridine (624 mg, 2 mmol) with 15 ml of 1,2-dimethoxyethane. Stir at room temperature for 30 minutes to bring the inside of the reactor into nitrogen atmosphere, 3,5-dinitrophenylboronic acid, pinacol ester (617 mg, 2.1 mmol) and tetrakis (triphenylphosphine) palladium (0) (Tetrakis 2 ml of (triphenylphosphine) palladium (0)) (60 mg, 5 mmol%) and 2M-Na 2 CO 3 solution were added and reacted for 24 hours while maintaining at 85 ° C. After the completion of the reaction, the reaction mixture was cooled to room temperature and 50 mL of distilled water was added to the reaction mass to terminate the reaction, and slightly acidified (PH = 5) with 2N-HCl. Filtration under reduced pressure, washing with distilled water several times, and prepared by recrystallization with methanol.

1H NMR (CDCl3): δ 9.14 (t, 1H), 9.06 (d, 2H), 8.82 (s, 2H), 8.72 (d, 2H), 8.69 (d, 2H), 7.92 (t, 2H), 7.42 (q, 2H) 1 H NMR (CDCl 3 ): δ 9.14 (t, 1H), 9.06 (d, 2H), 8.82 (s, 2H), 8.72 (d, 2H), 8.69 (d, 2H), 7.92 (t, 2H) , 7.42 (q, 2 H)

화합물 1Compound 1 (4′-(3,5-Diaminophenyl)-2,2′:6′,2′′-terpyridine)의 제조Preparation of (4 ′-(3,5-Diaminophenyl) -2,2 ′: 6 ′, 2 ′ ′-terpyridine)

Figure pat00023
Figure pat00023

4′-(3,5-디아니노페닐)-2,2′:6′,2′′-터피리딘(400 mg, 1 mmol)을 Ethanol 20 ml를 반응기에 넣는다. 5% Pd/C(53 mg, 5mol%)를 첨가한 후, Hydrazine hydrate 0.2 ml (4 mmol)을 주입하였다. 수소 가스가 발생됨을 확인 한 후, 80oC 승온하여 24시간 동안 반응시켰다. 반응 종료 후, 실온으로 냉각 시키고, 촉매를 여과하여 제거해 준다. Dichloromethane을 이용하여 추출하고 감압 하에서 용매를 제거한 후, 에탄올로 재결정 하여 제조 하였다. 20 ml of 4 '-(3,5-dianinophenyl) -2,2': 6 ', 2''-terpyridine (400 mg, 1 mmol) Ethanol is added to the reactor. After addition of 5% Pd / C (53 mg, 5 mol%), 0.2 ml (4 mmol) of Hydrazine hydrate was injected. After confirming that the hydrogen gas is generated, it was reacted for 24 hours by raising the temperature to 80 ° C. After the reaction was completed, the mixture was cooled to room temperature, and the catalyst was filtered off. Extraction was performed using dichloromethane, the solvent was removed under reduced pressure, and recrystallized with ethanol.

1H NMR (CDCl3): δ 8.73-8.64 (m, 6H), 7.88-7.85 (m, 2H), 7.24-7.18 (m, 2H), 6.66 (s, 2H), 6.23 (s, 1H), 3.71 (bs, 4H)
1 H NMR (CDCl 3 ): δ 8.73-8.64 (m, 6H), 7.88-7.85 (m, 2H), 7.24-7.18 (m, 2H), 6.66 (s, 2H), 6.23 (s, 1H), 3.71 (bs, 4H)

[실시예 2] 4'-(3,5-디아미노바이페닐)-2,2':6',2''-터피리딘(4'-(3,5-dinitrobiphenyl)-2,2':6',2''-terpyridine)의 제조Example 2 4 '-(3,5-diaminobiphenyl) -2,2': 6 ', 2' '-terpyridine (4'-(3,5-dinitrobiphenyl) -2,2 ': 6 ', 2' '-terpyridine)

화합물 2-1Compound 2-1 (4'-((4'-( pp -Bromophenyl)-2,2':6',2''-terpyridine)의 제조Preparation of -Bromophenyl) -2,2 ': 6', 2 ''-terpyridine)

Figure pat00024
Figure pat00024

4-브로모벤즈아데히드(4-bromobenzaldehyde)(2 g, 4.9 mmol), 2-아세틸피리딘(2-Acetylpyridine)(1.18 g, 9.8 mmol)과 NaOH (0.4 g, 9.8 mmol)을 사기 막자사발에 넣고 잘 섞는다. 노란색 고체가 생성될 때 까지 잘 간다. 생성된 고체를 물과 에탄올을 이용하여 씻어서 흰색 고체를 얻는다. 얻어진 흰색 고체를 건조 후에, 플라스크에 옮기고 암모늄 아세테이트(Ammonium acetate)(3 g, 과량)와 빙초산(Acetic acid)(30ml)를 넣어서 2시간 동안 교반, 환류한다. 반응 종료 후, 물을 첨가하여 침전을 생성시키고, 얻어진 침전물을 거른 후, 물과 에탄올로 씻어서 제조하였다. 4-bromobenzaldehyde (2 g, 4.9 mmol), 2-acetylpyridine (1.18 g, 9.8 mmol) and NaOH (0.4 g, 9.8 mmol) were placed in a mortar Put and mix well. Go well until a yellow solid is formed. The resulting solid is washed with water and ethanol to give a white solid. After drying, the obtained white solid was transferred to a flask, and stirred and refluxed for 2 hours by adding ammonium acetate (3 g, excess) and acetic acid (30 ml). After the reaction was completed, water was added to form a precipitate, and the obtained precipitate was filtered and washed with water and ethanol to prepare.

1H NMR (CDCl3): δ 8.82-8.59 (m, 6H), 7.88 (td, 2H), 7.75(d, 2H), 7.61 (d, 2H), 7.36 (t, 2H)
1 H NMR (CDCl 3 ): δ 8.82-8.59 (m, 6H), 7.88 (td, 2H), 7.75 (d, 2H), 7.61 (d, 2H), 7.36 (t, 2H)

화합물 2-2Compound 2-2 (4'-(3,5-dinitrobiphenyl)-2,2':6',2''-terpyridine)의 제조Preparation of (4 '-(3,5-dinitrobiphenyl) -2,2': 6 ', 2' '-terpyridine)

Figure pat00025
Figure pat00025

4'-브로모-2,2':6',2''-터피리딘 대신에 4'-(p-브로모페닐)-2,2':6',2''-터피리딘을 사용하고, 용매로 toluene을 사용한 외에는 화합물 1-8과 동일한 방법으로 제조하였다.4 '-( p -bromophenyl) -2,2': 6 ', 2''-terpyridine instead of 4'-bromo-2,2': 6 ', 2''-terpyridine , Except that toluene was used as the solvent was prepared in the same manner as in compound 1-8 .

1H NMR (CDCl3): δ 8.83 (t, 1H), 8.77 (d, 2H), 8.68 (s, 2H), 8.65 (d, 2H), 8.63 (d, 2H), 8.02 (t, 2H), 7.91 (d, 2H), 7.87 (d, 2H), 7.52 (q, 2H)
1 H NMR (CDCl 3 ): δ 8.83 (t, 1H), 8.77 (d, 2H), 8.68 (s, 2H), 8.65 (d, 2H), 8.63 (d, 2H), 8.02 (t, 2H) , 7.91 (d, 2H), 7.87 (d, 2H), 7.52 (q, 2H)

화합물 2(Compound 2 ( 4'-(3,5-dinitrobiphenyl)-2,2':6',2''-terpyridine)의 제조Preparation of 4 '-(3,5-dinitrobiphenyl) -2,2': 6 ', 2' '-terpyridine)

Figure pat00026
Figure pat00026

4′-(3,5-디아미노페닐)-2,2′:6′,2′′-터피리딘 대신에 4'-(3,5-디니트로바이페닐)-2,2':6',2''-터피리딘을 사용한 것 외에는 화합물 1과 동일한 방법으로 제조하였다.4 '-(3,5-diaminophenyl) -2,2': 6 ', 2''-terpyridine instead of 4'-(3,5-dinitrobiphenyl) -2,2 ': 6' Prepared by the same method as the compound 1 except using 2,2 ''-terpyridine.

1H NMR (CDCl3): δ 8.74-8.66 (m, 9H), 7.91-7.85 (m, 2H), 7.79 (d, 2H), 7.65(d, 2H), 7.38-7.34 (m, 2H), 3.21 (bs, 4H)
1 H NMR (CDCl 3 ): δ 8.74-8.66 (m, 9H), 7.91-7.85 (m, 2H), 7.79 (d, 2H), 7.65 (d, 2H), 7.38-7.34 (m, 2H), 3.21 (bs, 4H)

[실시예 3] 5-(3,5-디아미노페닐)-1,10-페난쓰롤린(5-(3,5-dinitrophenyl)-1,10-phenanthroline)의 제조Example 3 Preparation of 5- (3,5-diaminophenyl) -1,10-phenanthrosine (5- (3,5-dinitrophenyl) -1,10-phenanthroline)

화합물 3-1Compound 3-1 (5-Bromophenanthroline)의 제조Preparation of (5-Bromophenanthroline)

Figure pat00027
Figure pat00027

페난쓰롤린(phenanthroline)(1.2 g, 6.7 mmol)을 내압 설계된 반응기에 넣는다. 얼음 중탕 하에서 발연황산(oleum) (15%) 5ml와 Br2 0.2ml(4 mmol)을 적가한다. 바이톤(Viton) O-링이 있는 테프론 스크류 마개로 막고, 온도를 서서히 135oC 까지 올리고, 24시간동안 교반시킨다. 반응 종료 후, 실온으로 냉각 시키고, 얼음물에 붓고, 암모니아수(NH4OH)를 이용하여 중성화 시켜 준다. 클로로포름(CHCl3)으로 추출하고, 활성탄 처리 한 후, Na2SO4를 이용하여 건조한다. 감압 하에서 유기용매를 제거하고, 뜨거운 다이에틸이써(Diethlether)와 소량의 다이클로로메탄(CH2Cl2)을 이용하여 재결정하여 제조하였다.Phenanthroline (1.2 g, 6.7 mmol) is placed in a reactor designed for pressure. 5 ml of oleum (15%) and 0.2 ml (4 mmol) of Br 2 are added dropwise under an ice bath. Cover with a Teflon screw stopper with a Viton O-ring, slowly raise the temperature to 135 ° C and stir for 24 hours. After the reaction is completed, the mixture is cooled to room temperature, poured into ice water, and neutralized with ammonia water (NH 4 OH). Extracted with chloroform (CHCl 3 ), treated with activated charcoal, and dried over Na 2 SO 4 . The organic solvent was removed under reduced pressure, and recrystallized using hot diethlether and a small amount of dichloromethane (CH 2 Cl 2 ).

1H NMR (CDCl3): δ 9.17 (m, 2H), 8.64 (dd, 1H), 8.15 (dd, 1H), 8.12 (s, 1H), 7.72 (dd, 1H), 7.61 (dd, 1H)
1 H NMR (CDCl 3 ): δ 9.17 (m, 2H), 8.64 (dd, 1H), 8.15 (dd, 1H), 8.12 (s, 1H), 7.72 (dd, 1H), 7.61 (dd, 1H)

화합물 3-2Compound 3-2 (5-(3,5-dinitrophenyl)-1,10-phenanthroline)의 제조Preparation of (5- (3,5-dinitrophenyl) -1,10-phenanthroline)

Figure pat00028
Figure pat00028

4'-브로모-2,2':6',2''-터피리딘 대신에 5-브로모페난쓰롤린을 사용한 것 외에는 화합물 1-8과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Compound 1-8 , except that 5-bromophenanthrosine was used instead of 4'-bromo-2,2 ': 6', 2 ''-terpyridine.

1H NMR (CDCl3): δ 9.17 (m, 2H), 9.14 (t, 1H), 9.02 (d, 2H), 8.64 (dd, 1H), 8.15 (dd, 1H), 8.12 (s, 1H), 7.72 (dd, 1H), 7.61 (dd, 1H)
1 H NMR (CDCl 3 ): δ 9.17 (m, 2H), 9.14 (t, 1H), 9.02 (d, 2H), 8.64 (dd, 1H), 8.15 (dd, 1H), 8.12 (s, 1H) , 7.72 (dd, 1H), 7.61 (dd, 1H)

화합물 3Compound 3 (5-(3,5-dinitrophenyl)-1,10-phenanthroline)의 제조 Preparation of (5- (3,5-dinitrophenyl) -1,10-phenanthroline)

Figure pat00029
Figure pat00029

4′-(3,5-디니트로페닐)-2,2′:6′,2′′-터피리딘 대신에 5-(3,5-디니트로페닐)-1,10-페난쓰롤린을 사용한 것 외에는 화합물 1과 동일한 방법으로 제조하였다. 5- (3,5-dinitrophenyl) -1,10-phenanthrosine in place of 4 '-(3,5-dinitrophenyl) -2,2': 6 ', 2' '-terpyridine Except that, it was prepared in the same manner as in compound 1.

1H NMR (CDCl3): δ 9.12 (m, 2H), 8.62 (dd, 1H), 8.12 (dd, 1H), 8.10 (s, 1H), 7.70 (dd, 1H), 7.57 (dd, 1H), 6.72 (d, 2H), 5.83 (t, 1H), 4.21 (bs, 4H)
1 H NMR (CDCl 3 ): δ 9.12 (m, 2H), 8.62 (dd, 1H), 8.12 (dd, 1H), 8.10 (s, 1H), 7.70 (dd, 1H), 7.57 (dd, 1H) , 6.72 (d, 2H), 5.83 (t, 1H), 4.21 (bs, 4H)

[실시예 4] 4'-[4-(Bis-3,5-diaminophenoxy)phenyl]-2,2':6',2''-terpyridine의 제조Example 4 Preparation of 4 '-[4- (Bis-3,5-diaminophenoxy) phenyl] -2,2': 6 ', 2' '-terpyridine

화합물 4-1Compound 4-1 (4'-[4-(3,5-(4 '-[4- (3,5- dimethoxyphenyldimethoxyphenyl ]-2,2':6',2''-] -2,2 ': 6', 2 ''- terpyridineterpyridine )의 제조 Manufacturing

Figure pat00030
Figure pat00030

질소 분위기인 100 ml 삼구 플라스크 반응기에 화합물 2-1 4'-(p-Bromophenyl)-2,2':6',2''-terpyridine (3.8 g, 0.01 mol)을 1,2-디메톡시에탄 20 ml에 녹이고 3,5-디메톡시페닐보로닉 에시드, 피나콜 에스터(3,5-dimethoxyphenylboronic acid, pinacol ester)를 (3.2 g 0.012 mol)을 첨가 하고 화합물 1-8과 동일한 방법으로 제조하여 화합물 4-1을 75% 수득율로 얻었다. Compound 2-1 4 '-( p -Bromophenyl) -2,2': 6 ', 2''-terpyridine (3.8 g, 0.01 mol) was added to 1,2-dimethoxyethane in a 100 ml three-necked flask reactor in a nitrogen atmosphere. Dissolve in 20 ml and add 3,5-dimethoxyphenylboronic acid, pinacol ester (3.2 g 0.012 mol) and prepare in the same manner as Compound 1-8 Compound 4-1 was obtained in 75% yield.

Chemical Formula : C29H23N3O2 Chemical Formula: C 29 H 23 N 3 O 2

Molecular Weight : 445.51Molecular Weight: 445.51

GC-MS (m/z) : 445 (M+1, 100), 414 (23), 381(21), 223 (48)GC-MS (m / z): 445 (M +1 , 100), 414 (23), 381 (21), 223 (48)

Elemental Analysis (%) : C, 78.18; H, 5.20; N, 9.43; O, 7.18
Elemental Analysis (%): C, 78.18; H, 5.20; N, 9.43; O, 7.18

화합물 4-2Compound 4-2 (4'-[4-(3,5-dihydroxyphenyl]-2,2':6',2''-terpyridine)의 제조Preparation of (4 '-[4- (3,5-dihydroxyphenyl] -2,2': 6 ', 2' '-terpyridine)

Figure pat00031
Figure pat00031

화합물4-1 (2.2 g, 5 mmol)을 디클로로메탄 20 ml에 녹이고 어름 냉각 상태에서 히드로브롬산 4 ml을 30분에 걸쳐 서서히 적가하고 실온에서 24시간 교반하여 화합물 4-2 (4-(3,5-디히드록시페닐)-2,2':6',2''-터피리딘)을 80% 수득율로 얻었다. Compound 4-1 (2.2 g, 5 mmol) was dissolved in 20 ml of dichloromethane, and 4 ml of hydrobromic acid was slowly added dropwise over 30 minutes in an ice-cold state, followed by stirring at room temperature for 24 hours, to obtain Compound 4-2 (4- (3 , 5-dihydroxyphenyl) -2,2 ': 6', 2 ''-terpyridine) was obtained in 80% yield.

Chemical Formula : C27H19N3O2 Chemical Formula: C 27 H 19 N 3 O 2

Molecular Weight : 417.46Molecular Weight: 417.46

GC-MS (m/z) : 417 (M+1, 100), 400 (53), 383(41)GC-MS (m / z): 417 (M +1 , 100), 400 (53), 383 (41)

Elemental Analysis : C, 77.68; H, 4.59; N, 10.07; O, 7.67Elemental Analysis: C, 77.68; H, 4.59; N, 10.07; O, 7.67

1H NMR (DMSO) :δ 9.35-9.11 (m, 4H), 8.61-8.54 (m, 2H), 7.91-7.89 (m, 2H), 7.32-7.12 (m, 6H), 6.89 (s, 2H), 6.23 (s, 1H), 5.38 (bs, 2H)
1 H NMR (DMSO): δ 9.35-9.11 (m, 4H), 8.61-8.54 (m, 2H), 7.91-7.89 (m, 2H), 7.32-7.12 (m, 6H), 6.89 (s, 2H) , 6.23 (s, 1H), 5.38 (bs, 2H)

화합물 4-3 Compound 4-3 (4'-[4-(Bis-3,5-dinitrophenoxy)phenyl]-2,2':6',2''(4 '-[4- (Bis-3,5-dinitrophenoxy) phenyl] -2,2': 6 ', 2' '

-- terpyridineterpyridine )의 제조 Manufacturing

Figure pat00032
Figure pat00032

질소 분위기인 100 ml 삼구 플라스크에 화합물 4-2(4.17 g, 0.01 mol)과 1-브로모-4-니트로벤젠(4.6 g, 0.023 mol)을 넣고 DMSO 50 ml로 녹인다. 그 후 수산화칼륨(1.3 g 0.023 mol)을 적가하고 반응기 온도를 95 oC로 하여 24시간 반응하고 실온으로 냉각하여 증류수 200 ml을 비이커에 담고 이곳에 반응 물질을 첨가하여 흰색 고체를 얻었다. 이것을 여과 후 증류수로 2~3회 세척하고 에탄올로 수차례 세척하여 결정체를 건조하여 백색 결정체인 화합물 4-3을 (5.27 g 80 %)얻었다. Compound 4-2 (4.17 g, 0.01 mol) and 1-bromo-4-nitrobenzene (4.6 g, 0.023 mol) were added to a 100 ml three-necked flask with nitrogen atmosphere and dissolved in 50 ml of DMSO. Thereafter, potassium hydroxide (1.3 g 0.023 mol) was added dropwise, and the reaction temperature was allowed to react at 95 ° C. for 24 hours. After cooling to room temperature, 200 ml of distilled water was added to a beaker, and the reaction material was added thereto to obtain a white solid. This was filtered, washed 2-3 times with distilled water and washed several times with ethanol to dry the crystals to give compound 4-3 (5.27 g 80%) as a white crystals.

Chemical Formula : C39H25N5O6 Chemical Formula: C 39 H 25 N 5 O 6

Molecular Weight : 659.65Molecular Weight: 659.65

GC-MS (m/z) : 659 (M+1, 64), 613 (48), 567(38), 521 (100)GC-MS (m / z): 659 (M +1 , 64), 613 (48), 567 (38), 521 (100)

Elemental Analysis : C, 70.10; H, 3.63; N, 10.82; O, 15.45Elemental Analysis: C, 70.10; H, 3.63; N, 10.82; O, 15.45

1H NMR (DMSO) :δ 9.26-9.12 (m, 4H), 8.52 (d, 2H), 8.23 (d, 4H), 7.94-7.88 (m, 2H), 7.23-7.01 (m, 12H), 6.81 (s, 1H)
1 H NMR (DMSO): δ 9.26-9.12 (m, 4H), 8.52 (d, 2H), 8.23 (d, 4H), 7.94-7.88 (m, 2H), 7.23-7.01 (m, 12H), 6.81 (s, 1H)

화합물 4 Compound 4 (4'-[4-(Bis-3,5-diaminophenoxy)phenyl]-2,2':6',2''(4 '-[4- (Bis-3,5-diaminophenoxy) phenyl] -2,2': 6 ', 2' '

-- terpyridineterpyridine )의 제조Manufacturing

Figure pat00033
Figure pat00033

수소화 반응기에 화합물 4-3(5 g, 7.5 mmol)을 에탄올 40ml와 DMF 40 ml에 녹이고 5% Pd/C (0.01 g)를 적가하고 24시간 교반하여 TLC와 KMnO4 용액으로 산화시켜 반응진행을 확인 종결하여 촉매를 여과하고 여액을 농축하여 결정체를 얻었다. 에탄올로 재결정하여 백색 결정인 화합물 4 3.4 g 75%)을 얻었다. Compound 4-3 (5 g, 7.5 mmol) was dissolved in 40 ml of ethanol and 40 ml of DMF in a hydrogenation reactor, and 5% Pd / C (0.01 g) was added dropwise and stirred for 24 hours to oxidize with TLC and KMnO 4 solution. Upon completion of the identification, the catalyst was filtered off and the filtrate was concentrated to obtain crystals. Recrystallization with ethanol afforded 3.4 g 75% of compound 4 as white crystals.

Chemical Formula : C39H29N5O2 Chemical Formula: C 39 H 29 N 5 O 2

Molecular Weight : 599.68Molecular Weight: 599.68

GC-MS (m/z) : 599 (M+1, 100), 491 (78), 383(54)GC-MS (m / z): 599 (M +1 , 100), 491 (78), 383 (54)

Elemental Analysis : C, 78.11; H, 4.87; N, 11.68; O, 5.34Elemental Analysis: C, 78.11; H, 4.87; N, 11.68; O, 5.34

1H NMR (DMSO) :δ 9.35-9.11 (m, 4H), 8.54 (d, 2H), 7.89 (d, 4H), 7.32-7.12 (m, 6H), 6.89-6.65 (m, 8H), 6.83 (s, 1H), 6.23 (bs, 4H)
1 H NMR (DMSO): δ 9.35-9.11 (m, 4H), 8.54 (d, 2H), 7.89 (d, 4H), 7.32-7.12 (m, 6H), 6.89-6.65 (m, 8H), 6.83 (s, 1H), 6.23 (bs, 4H)

[실시 예 5] [Example 5] 터피리딘기Terpyridine groups 기능기를Function 포함하는 폴리이미드의 제조 Preparation of polyimide containing

Figure pat00034
Figure pat00034

250ml 3구 플라스크에서 터피리딘 구조를 함유하는 화합물 1 (디아민(4′-(3,5-디아미노페닐)-2,2′:6′,2′′-터피리딘))(3.39 g, 0.01 mol)을 디메틸아세틸아마이드 81 g에 녹인 후 얼음물로 반응온도를 5도 이하로 제어하여 PMDA(1,2,4,5-benzenetetracarboxylic dianhydride; pyromellitic dianhydride)(5.56 g, 0.01 mol)을 서서히 첨가하여 얼음물이 녹음에 따라 상온으로 유지하며 12시간 반응하는 1:1 용액중합과정을 통하여 고형분 함량이 10%인 폴리이미드 전구체인 폴리아믹산(PAA)을 제조하였다.
Compound 1 (diamine (4 ′-(3,5-diaminophenyl) -2,2 ′: 6 ′, 2 ′ ′-terpyridine)) containing terpyridine structure in a 250 ml three neck flask (3.39 g, 0.01 mol) was dissolved in 81 g of dimethylacetylamide, and then the reaction temperature was controlled to 5 degrees or less with ice water. Then, PMDA (1,2,4,5-benzenetetracarboxylic dianhydride; pyromellitic dianhydride) (5.56 g, 0.01 mol) was slowly added to the ice water. The polyamic acid (PAA), a polyimide precursor having a solid content of 10%, was prepared through a 1: 1 solution polymerization process which was maintained at room temperature according to this recording and reacted for 12 hours.

이와 같이 제조한 폴리아믹산은 필름어플리케이터를 이용하여 필름캐스팅하여 80도 30분, 200도 30분, 370도 30분 대류오븐에서 열처리하여 50um 두께의 폴리이미드(PI) 필름을 제조하였다.
The polyamic acid thus prepared was subjected to film casting using a film applicator, followed by heat treatment in a convection oven at 80 degrees 30 minutes, 200 degrees 30 minutes, and 370 degrees 30 minutes to prepare a polyimide (PI) film having a thickness of 50 μm.

상기에 나타낸 바와 같이, 본 발명에 따른 터피리딘을 함유한 디아민은 디안하이드라이드와 반응하여 축합중합방법에 의해 고분자를 합성할 수 있으며 이를 통해 합성된 고분자는 금속과 배위결합할 수 있는 기능기를 함유하고 있어 금속과 배위결합이 가능하다. As shown above, the diamine containing terpyridine according to the present invention can synthesize a polymer by a condensation polymerization method by reacting with dianhydride, and the synthesized polymer contains a functional group capable of coordinating with a metal. Coordination bond with metal is possible.

이상의 결과에서 본 발명에서 제시하는 방법을 통해 고분자 매트릭스에 터피리딘 구조를 도입함에 의해 배위 특성을 향상시켜 다양한 분야로 응용이 가능할 것으로 본다.In view of the above results, by introducing a terpyridine structure into the polymer matrix through the method proposed in the present invention, the coordination property is improved, and thus it may be applicable to various fields.

Claims (5)

하기 화학식 1로 표시되는 터피리딘기 또는 페난쓰롤린기를 포함하는 디아민 화합물.
[화학식 1]
Figure pat00035

[상기 화학식 1에서,
R은 아민기 또는 -O-Ar-NH2이며, Ar은 C6~C12아릴이며;
n은 0 내지 2의 상수이며;
A는 하기 구조식에서 선택되는 어느 하나이다.]
Figure pat00036
Diamine compound containing a terpyridine group or a phenanthrosine group represented by the following formula (1).
[Formula 1]
Figure pat00035

[In the above formula (1)
R is an amine group or -O-Ar-NH 2 , and Ar is C 6 -C 12 aryl;
n is a constant from 0 to 2;
A is any one selected from the following structural formulas.]
Figure pat00036
하기 화학식 2의 화합물과 하기 화학식 3의 화합물을 반응시켜 하기 화학식 4의 화합물을 제조하는 단계;
하기 화학식 4의 화합물을 환원하여 하기 화학식 1a의 화합물을 제조하는 단계;를 포함하는 터피리딘기 또는 페난쓰롤린기를 포함하는 디아민 화합물의 제조방법.
[화학식 1a]
Figure pat00037

[화학식 2]
Figure pat00038

[화학식 3]
A-X
[화학식 4]
Figure pat00039

[화학식 1a, 화학식 2 내지 화학식 4에서,
n은 0 내지 2의 상수이며;
X는 할로겐이며;
A는 하기 구조식에서 선택되는 어느 하나이다.]
Figure pat00040
Preparing a compound of Chemical Formula 4 by reacting a compound of Chemical Formula 2 with a compound of Chemical Formula 3;
A method for preparing a diamine compound comprising a terpyridine group or a phenanthrosine group, the method comprising: reducing a compound of Formula 4 to produce a compound of Formula 1a.
[Formula 1a]
Figure pat00037

(2)
Figure pat00038

(3)
AX
[Chemical Formula 4]
Figure pat00039

[Formula 1a, Formula 2 to Formula 4,
n is a constant from 0 to 2;
X is halogen;
A is any one selected from the following structural formulas.]
Figure pat00040
제 2항에 있어서,
상기 화학식 2의 화합물은, 하기 화학식 6의 화합물로 하기 화학식 7을 제조하는 단계;
하기 화학식 7을 하기 화학식 2로 제조하는 단계;를 포함하여 제조되는 터피리딘기 또는 페난쓰롤린기를 포함하는 디아민 화합물의 제조방법.
[화학식 6]
Figure pat00041

[화학식 7]
Figure pat00042

[상기 화학식 6 또는 7에서, X는 할로겐이다.]
The method of claim 2,
The compound of Formula 2 is prepared by the following formula (7) to the compound of formula (6);
A method for preparing a diamine compound comprising a terpyridine group or a phenanthrosine group prepared by the following Formula 7;
[Chemical Formula 6]
Figure pat00041

(7)
Figure pat00042

[In Formula 6 or 7, X is a halogen.]
하기 화학식 3의 화합물과 하기 화학식의 8화합물을 반응시켜 하기 화학식 9의 화합물을 제조하는 단계;
하기 화학식 9을 산화하여 하기 화학식 10의 화합물을 제조하는 단계;
하기 화학식 10의 화합물과 하기 화학식 11의 화합물을 반응하여 하기 화학식 12의 화합물을 제조하는 단계;
하기 화학식 12의 화합물을 환원하여 하기 화학식 1b의 화합물을 제조하는 단계;를 포함하는 터피리딘기 또는 페난쓰롤린기를 포함하는 디아민 화합물의 제조방법.
[화학식 1b]
Figure pat00043

[화학식 3]
A-X
[화학식 8]
Figure pat00044

[화학식 9]
Figure pat00045

[화학식 10]
Figure pat00046

[화학식 11]
Figure pat00047

[화학식 12]
Figure pat00048

[화학식 1b, 화학식 3 및 화학식 8 내지 화학식 12에서,
X는 할로겐이며; A 또는 Ar은 제 1항의 화학식 1에서의 정의와 동일하다.]
Preparing a compound of Chemical Formula 9 by reacting the compound of Chemical Formula 3 with the compound of Chemical Formula 8;
Preparing a compound of Chemical Formula 10 by oxidizing Chemical Formula 9;
Preparing a compound of Chemical Formula 12 by reacting a compound of Chemical Formula 10 with a compound of Chemical Formula 11;
A method for preparing a diamine compound comprising a terpyridine group or a phenanthrosine group, the method comprising: reducing a compound of Formula 12 to produce a compound of Formula 1b.
[Chemical Formula 1b]
Figure pat00043

(3)
AX
[Chemical Formula 8]
Figure pat00044

[Chemical Formula 9]
Figure pat00045

[Formula 10]
Figure pat00046

(11)
Figure pat00047

[Chemical Formula 12]
Figure pat00048

In Chemical Formula 1b, Chemical Formula 3, and Chemical Formulas 8 to 12,
X is halogen; A or Ar is the same as defined in formula 1 of claim 1.]
하기 화학식 1로 표시되는 터피리딘기 또는 페난쓰롤린기를 포함하는 디아민 화합물과 디안하이드라이드, 디카복실산 및 디에스터에서 선택되는 하나 또는 둘이상의 혼합물을 반응하여 제조된 중합체.
[화학식 1]
Figure pat00049

[상기 화학식 1에서,
R은 아민기 또는 -O-Ar-NH2이며, Ar은 C6~C12아릴이며;
n은 0 내지 2의 상수이며;
A는 하기 구조식에서 선택되는 하나이다.]
Figure pat00050
A polymer prepared by reacting a diamine compound comprising a terpyridine group or a phenanthrosine group represented by Formula 1 with one or more mixtures selected from dianhydrides, dicarboxylic acids and diesters.
[Formula 1]
Figure pat00049

[In the above formula (1)
R is an amine group or -O-Ar-NH 2 , and Ar is C 6 -C 12 aryl;
n is a constant from 0 to 2;
A is one selected from the following structural formulas.]
Figure pat00050
KR1020110039621A 2011-04-27 2011-04-27 Novel diamine compound containing terpyridine or phenanthroline and method use the same KR101311767B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020110039621A KR101311767B1 (en) 2011-04-27 2011-04-27 Novel diamine compound containing terpyridine or phenanthroline and method use the same
PCT/KR2012/002367 WO2012148090A2 (en) 2011-04-27 2012-03-30 Production of diamine having a novel structure containing a terpyridine or phenanthroline functional group and a use therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020110039621A KR101311767B1 (en) 2011-04-27 2011-04-27 Novel diamine compound containing terpyridine or phenanthroline and method use the same

Publications (2)

Publication Number Publication Date
KR20120121677A true KR20120121677A (en) 2012-11-06
KR101311767B1 KR101311767B1 (en) 2013-09-26

Family

ID=47072848

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020110039621A KR101311767B1 (en) 2011-04-27 2011-04-27 Novel diamine compound containing terpyridine or phenanthroline and method use the same

Country Status (2)

Country Link
KR (1) KR101311767B1 (en)
WO (1) WO2012148090A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108659220B (en) * 2018-05-30 2021-05-04 江西师范大学 Polyimide containing terpyridine structure and preparation method thereof
CN108530344B (en) * 2018-05-30 2023-11-03 江西师范大学 Aromatic diamine containing bipyridine structure and synthesis method thereof
CN108659221B (en) * 2018-05-30 2022-01-11 江西师范大学 Polyimide metal complex with high dielectric constant and containing terpyridine unit and preparation method thereof
CN109320730B (en) * 2018-09-21 2021-04-16 重庆师范大学 Barium-organic coordination polymer, preparation method thereof and application thereof in ion detection and green light composite film preparation
CN113512000A (en) * 2021-04-29 2021-10-19 河南阿尔法医药科技有限公司 Method for large-scale production of 4 '-bromo-2, 2', 6 ', 2' -terpyridine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774082B2 (en) * 2001-05-11 2004-08-10 Ibc Advanced Technologies, Inc. Compositions for separating heterocyclic aromatic amine bases, nucleosides, nucleotides, and nucleotide sequences
EP2169028B1 (en) * 2002-03-22 2018-11-21 Idemitsu Kosan Co., Ltd. Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
KR100747312B1 (en) * 2005-07-15 2007-08-07 엘지전자 주식회사 Electron Transport Chemical and Organic Light Emitting Diodes

Also Published As

Publication number Publication date
WO2012148090A2 (en) 2012-11-01
WO2012148090A3 (en) 2012-12-20
KR101311767B1 (en) 2013-09-26

Similar Documents

Publication Publication Date Title
KR101311767B1 (en) Novel diamine compound containing terpyridine or phenanthroline and method use the same
JP2014517820A (en) Stannyl derivatives of naphthalene diimide and related compositions and methods
CN102627522B (en) Synthesis method of indenofluorene derivatives, isotruxene and mono-substituted isotruxene derivatives
US10294255B1 (en) Multifunctional crosslinking agent, crosslinked polymer, and method of making same
Wang et al. Synthesis and characterization of triphenylamine–benzothiazole-based donor and acceptor materials
CN108251128B (en) Liquid crystal compound with negative dielectric anisotropy and preparation method and application thereof
CN111592533B (en) 1,2, 4-oxadiazole bipyridyl substituted benzamide compound and preparation method and application thereof
CN110256493B (en) C2-phosphonoindole compound and preparation method thereof
JP6917999B2 (en) M-terphenyl as a protecting group for poly (phenylene) and benzoimidazolium hydroxide
CN110452267A (en) The phosphorylated qualone derivative and preparation method and application that a kind of 3- replaces
CN102604095A (en) N-substituted polybenzimidazole amide compound and preparation method thereof
CN102924534B (en) 4,4'-diamido-4''-ferrocenyl triphenylamine and preparation method thereof
CN101870693A (en) Bismaleimide containing 1,3,4-oxadiazole structure and preparation method thereof
CN109485582B (en) Fluorenone-based organogel molecule and preparation method and application thereof
JP7427318B2 (en) Novel compounds and organic light-emitting devices using them
Lu et al. Synthesis of Unsymmetrical Diarylfumaronitriles via Tandem Michael Addition and Oxidation under K3Fe (CN) 6/O2 System
CN106966922A (en) A kind of synthetic method of the dicyanoethylene class compound of functionalization substitution
TWI359152B (en) Phosphorus-containing compounds with various subst
JP6319979B2 (en) Boron-containing compound and boron-containing polymer
JP4333473B2 (en) Metal complex-containing fluorene compound and method for producing the same
Chopin et al. Trifluoromethyl-derived enaminones and their difluoroboron complexes: Synthesis, crystal structure and electrochemistry properties
JP2016047906A (en) Method for producing five-membered heteroarylene-vinylene polymer
JP6654900B2 (en) Cycloparaphenylene compound, production method thereof and intermediate compound
Kausar et al. Novel thermally stable poly (thiourea–amide–imide) s bearing CS moieties and pyridine units in the backbone: Synthesis and properties
CN103467353A (en) Bismaleimide containing fluorenyl and aromatic ether bond structure, and preparation method thereof

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20170316

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20171102

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20180917

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20190918

Year of fee payment: 7